• Ono Pharmaceutical average return on equity for 2023 was 15.8, a 7.63% decline from 2022.
• Ono Pharmaceutical average return on equity for 2022 was 14.68, a 11.3% increase from 2021.
• Ono Pharmaceutical average return on equity for 2021 was 13.19, a 11.69% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.